{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:12:51Z","timestamp":1779927171441,"version":"3.53.1"},"reference-count":34,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Clin Pharmacol"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Propranolol is licensed in the UK and elsewhere to relieve symptoms of anxiety. In overdose, propranolol poisoning can be serious, difficult to treat and potentially fatal. This paper describes cases of intentional propranolol overdose reported to the UK National Poisons Information Service in order to raise awareness of the risk of harm following propranolol overdose and support safer prescribing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study reviews enquiries to UK Poison Centres involving intentional overdoses of propranolol requiring hospital attendance and reported between 1 January 2022 and 31 December 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There were 444 enquiries about 363 intentional propranolol overdoses in 359 different patients (248 [69%] women). Median age [interquartile range, IQR] was 32 [22\u201345] years (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009355); 52 (14%) patients were &lt;18\u2009years old. The indication was known in 121 (33%) cases, and was anxiety in 111. In 43\/61 cases where propranolol and an antidepressant were co\u2010prescribed, patients took both in overdose. The outcome was confirmed in 159 (44%) exposures; 110 patients recovered completely, 13 had ongoing features, one had permanent sequelae, and 35 died.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Overdose patients were often prescribed propranolol for anxiety, and many developed systemic toxicity. Despite intensive treatment, many patients still die from poisoning with propranolol alone or in combination with other agents. Given the dangers of propranolol in overdose, prescribers based in primary care settings should recognize that using propranolol to manage anxiety can be dangerous.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/bcp.70147","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T02:29:11Z","timestamp":1751596151000},"page":"3114-3120","source":"Crossref","is-referenced-by-count":3,"title":["The problem of propranolol poisoning"],"prefix":"10.1002","volume":"91","author":[{"given":"Hayley","family":"Williams","sequence":"first","affiliation":[{"name":"National Poisons Information Service (Birmingham Unit)  Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6869-9482","authenticated-orcid":false,"given":"Pardeep","family":"Jagpal","sequence":"additional","affiliation":[{"name":"National Poisons Information Service (Birmingham Unit)  Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euan","family":"Sandilands","sequence":"additional","affiliation":[{"name":"National Poisons Information Service (Edinburgh Unit)  Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Morrison","sequence":"additional","affiliation":[{"name":"National Poisons Information Service (Edinburgh Unit)  Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Gray","sequence":"additional","affiliation":[{"name":"National Poisons Information Service (Cardiff Unit)  Cardiff UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry Krishna Ruben","family":"Thanacoody","sequence":"additional","affiliation":[{"name":"National Poisons Information Service (Newcastle Unit)  Newcastle UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisha","family":"Beg","sequence":"additional","affiliation":[{"name":"Church Street Medical Practice Oxfordshire Clinical Commissioning Group  Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Bradberry","sequence":"additional","affiliation":[{"name":"National Poisons Information Service (Birmingham Unit)  Birmingham UK"},{"name":"West Midlands Poisons Unit Sandwell and West Birmingham NHS Trust  Birmingham UK"},{"name":"University of Birmingham  Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3769-1346","authenticated-orcid":false,"given":"Robin","family":"Ferner","sequence":"additional","affiliation":[{"name":"National Poisons Information Service (Birmingham Unit)  Birmingham UK"},{"name":"West Midlands Poisons Unit Sandwell and West Birmingham NHS Trust  Birmingham UK"},{"name":"University of Birmingham  Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(65)92340-8"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(66)91863\u20100"},{"key":"e_1_2_12_4_1","unstructured":"World Anti\u2010Doping Agency.The prohibited list 2024.https:\/\/www.wada-ama.org\/en\/prohibited-list?item-id=5040"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)90890-X"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(74)92060-1"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002\u20108703(84)90599\u20104"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881115612236"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.22744"},{"key":"e_1_2_12_10_1","unstructured":"Electronic Medicines Compendium.Propranolol 10mg film\u2010coated tablets2022[updated 18\/07\/2022].https:\/\/www.medicines.org.uk\/emc\/product\/11811\/smpc#gref"},{"key":"e_1_2_12_11_1","unstructured":"National Institute for Health and Care Excellence.Generalised anxiety disorder and panic disorder in adults: management 2020 [updated 15\/06\/2020; 09\/07\/2024].https:\/\/www.nice.org.uk\/guidance\/cg113\/resources\/generalised-anxiety-disorder-and-panic-disorder-in-adults-management-pdf-35109387756997"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2024.2435397"},{"issue":"6","key":"e_1_2_12_13_1","first-page":"423","article-title":"Can poisons centre data inform safer prescribing? A pilot review of propranolol exposures reported to the UK National Poisons Information Service (NPIS)","volume":"57","author":"Williams HA","year":"2019","journal-title":"Clin Toxicol"},{"issue":"6","key":"e_1_2_12_14_1","first-page":"537","article-title":"A 1\u2010year prospective analysis of propranolol exposures reported to the UK National Poisons Information Service (NPIS)","volume":"59","author":"Williams HA","year":"2021","journal-title":"Clin Toxicol"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/emermed-2022-RCEM2.30"},{"key":"e_1_2_12_16_1","first-page":"1","article-title":"Fatal propranolol overdoses reported to the UK National Poisons Information Service (NPIS) over 5 years, 2017\u20102021","volume":"60","author":"Williams HA","year":"2022","journal-title":"Clin Toxicol"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.3109\/15563659809028940"},{"key":"e_1_2_12_18_1","unstructured":"World Health Organization.Guidelines for establishing a poison centre Geneva 2020.https:\/\/www.who.int\/publications\/i\/item\/9789240009523"},{"key":"e_1_2_12_19_1","unstructured":"The confidence interval of a proportion 2025.http:\/\/vassarstats.net\/prop1.html"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.16177"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.16178"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650701233370"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2022.2077748"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13169"},{"key":"e_1_2_12_25_1","first-page":"1","article-title":"A one\u2010year prospective survey of propranolol enquiries to UK National Poisons Information Service","volume":"62","author":"Williams HA","year":"2024","journal-title":"Clin Toxicol"},{"key":"e_1_2_12_26_1","unstructured":"Office for National Statistics.Number of drug\u2010poisoning deaths where propranolol was mentioned on the death certificate England and Wales registered between 1993 and 20172018[updated 20\/12\/2018; 09\/07\/2024].https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/deaths\/adhocs\/009457numberofdrugpoisoningdeathswherepropranololwasmentionedonthedeathcertificateenglandandwalesregisteredbetween1993and2017"},{"key":"e_1_2_12_27_1","unstructured":"Office for National Statistics.Drug poisoning deaths where propranolol was mentioned on the death certificate England and Wales registered between 2016 and 2022.https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/deaths\/adhocs\/2252drugpoisoningdeathswherepropranololwasmentionedonthedeathcertificateenglandandwalesregisteredbetween2016and2022"},{"key":"e_1_2_12_28_1","unstructured":"Healthcare Safety Investigation Branch.2020Potential under\u2010recognised risk of harm from the use of propranolol."},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2024.714"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264\u2010017\u20100588\u20100"},{"issue":"50","key":"e_1_2_12_31_1","article-title":"Limited evidence for effect and safety of propranolol for exam\u2010related anxiety","volume":"180","author":"Vinther S","year":"2018","journal-title":"Ugeskr Laeger"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2016.0079"},{"key":"e_1_2_12_33_1","unstructured":"Bennett Institute for Applied Data Science.OpenPrescribing.netUniversity of Oxford;2024."},{"issue":"21","key":"e_1_2_12_34_1","first-page":"1","article-title":"Committee on Safety of Medicines. Benzodiazepines, dependence and withdrawal symptoms","year":"1988","journal-title":"Current Problems"},{"key":"e_1_2_12_35_1","article-title":"Exploring GPs' views on beta\u2010blocker prescribing for people with anxiety disorders: a qualitative study","author":"Archer C","year":"2024","journal-title":"Br J Gen Pract"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bcp.70147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:21:44Z","timestamp":1761722504000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1002\/bcp.70147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1002\/bcp.70147"],"URL":"https:\/\/doi.org\/10.1002\/bcp.70147","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]}}}